Back
ESC Premium Access

Benefit-risk profile of dabigatran compared with vitamin-K antagonists in elderly patients with non-valvular atrial fibrillation: results from a cohort study in the French nationwide claims database

Session: Poster Session 4 - Atrial fibrillation - Stroke prevention
Topic: Oral Anticoagulation
Speaker: Professor Y. Cottin (Dijon, FR)
Event: ESC Congress 2018

Congress Presentation

Add to my library

Like

About the speaker

Professor Yves Cottin

University Hospital of Dijon, Dijon (France)
0 follower

27 more presentations in this session

The prognostic accuracy of bleeding risk prediction scores in patients with atrial fibrillation: a systematic review and meta-analysis.

Speaker: Professor P. Penson (Liverpool, GB)

Access
Abstract
Slides
Like
Thumbnail

Net clinical benefit of NOACs vs. VKAs in elderly patients with atrial fibrillation: a pooled analysis from the real-world PREFER in AF and PREFER in AF PROLONGATION registries

Speaker: Doctor I. Cavallari (Rome, IT)

Access
Abstract
Slides
Like
Thumbnail

A meta-analysis of efficacy and safety of Watchman device for left atrial appendage closure in non-valvular atrial fibrillation

Speaker: Doctor A. Jhand (Omaha, US)

Access
Abstract
Slides
Like
Thumbnail

A metaanlysis for safety and efficacy of amplatzer cardiac plug and amulet device for left atrial appendage closure in patiets with non valvular atrial fibrillation

Speaker: Doctor A. Thandra (Omaha, US)

Access
Abstract
Slides
Like
Thumbnail

Use of oral anticoagulation is less among hospitalized patients with paroxysmal compared to persistent or permanent atrial fibrillation

Speaker: Doctor S. Pokorney (Durham, US)

Access
Like
Thumbnail

Access the full session

Poster Session 4 - Atrial fibrillation - Stroke prevention

Speakers: Professor Y. Cottin, Professor P. Penson, Doctor I. Cavallari, Doctor A. Jhand, Doctor A. Thandra...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources